Luca Valenti
Luca Valenti
Associate Professor of Internal Medicine, UniversitÓ degli Studi di Milano, Fondazione Ca' Granda
Verified email at
Cited by
Cited by
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes
D Frescas, L Valenti, D Accili
Journal of Biological Chemistry 280 (21), 20589-20595, 2005
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ...
Gastroenterology 122 (2), 274-280, 2002
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
Genetics and epigenetics of NAFLD and NASH: clinical impact
M Eslam, L Valenti, S Romeo
Journal of hepatology 68 (2), 268-279, 2018
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ...
American Journal of Gastroenterology 102 (6), 1251-1258, 2007
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
S Fargion, M Mattioli, AL Fracanzani, M Sampietro, D Tavazzi, P Fociani, ...
The American journal of gastroenterology 96 (8), 2448-2455, 2001
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target
P Dongiovanni, AL Fracanzani, S Fargion, L Valenti
Journal of hepatology 55 (4), 920-932, 2011
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
AL Fracanzani, L Burdick, S Raselli, P Pedotti, L Grigore, G Santorelli, ...
The American journal of medicine 121 (1), 72-78, 2008
I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ...
Hepatology 52 (4), 1274-1280, 2010
Statin use and non-alcoholic steatohepatitis in at risk individuals
P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ...
Journal of hepatology 63 (3), 705-712, 2015
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ...
Human molecular genetics 23 (15), 4077-4085, 2014
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
A new definition for metabolic associated fatty liver disease: an international expert consensus statement
M Eslam, PN Newsome, QM Anstee, G Targher, MR Gomez, ...
Journal of hepatology, 2020
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data
E TrÚpo, P Nahon, G Bontempi, L Valenti, E Falleti, HD Nischalke, ...
Hepatology 59 (6), 2170-2177, 2014
The system can't perform the operation now. Try again later.
Articles 1–20